Drug Discovery

How Does Proper COA Selection Influence Drug Development Success?
Research & Development How Does Proper COA Selection Influence Drug Development Success?

Clinical Outcome Assessments (COAs) play a pivotal role in the drug development process. These tools, which measure the impact of a treatment on patients' health status, encompass several types: Patient-Reported Outcomes (PROs), Clinician-Reported Outcomes (ClinROs), Observer-Reported Outcomes

Lundbeck Acquires Longboard for $2.6B to Boost Neurology Portfolio
Research & Development Lundbeck Acquires Longboard for $2.6B to Boost Neurology Portfolio

Lundbeck, the Danish drugmaker, has announced its acquisition of Longboard Pharmaceuticals for $2.6 billion, centering the deal around Longboard's promising experimental brain medicine, bexicaserin. This medicine is in late-stage clinical testing for treating developmental and epileptic

Skysona's Promise and Risk: Treating CALD but Facing Cancer Concerns
Research & Development Skysona's Promise and Risk: Treating CALD but Facing Cancer Concerns

The approval of Bluebird bio's gene therapy, Skysona, in September 2022 by the FDA marked a significant milestone for treating cerebral adrenoleukodystrophy (CALD), a rare and fatal childhood brain disorder. Skysona's innovation generated hope for families dealing with CALD, yet recent

Who Will Win the Race to Develop Cutting-Edge Obesity Drugs?
Research & Development Who Will Win the Race to Develop Cutting-Edge Obesity Drugs?

In a dynamic twist within the pharmaceutical industry, several companies are locked in a fierce race to develop the next generation of obesity drugs. As the battle heats up, each aims to outdo the other, with innovations that promise to revolutionize the way obesity is treated. This race isn't

Enhanced Biopharma Efficiency with Raman Spectroscopy
Research & Development Enhanced Biopharma Efficiency with Raman Spectroscopy

The biopharmaceutical industry is rapidly evolving, fueled by cutting-edge technologies and scientific breakthroughs. Novel treatments such as cell and gene therapies, biologics, and vaccines are reaching the market at unprecedented speeds. However, the rigorous journey from drug development to

Controversy Over Cassava's Alzheimer's Drug Spurs Ethical Concerns
Research & Development Controversy Over Cassava's Alzheimer's Drug Spurs Ethical Concerns

The controversy surrounding Cassava Sciences and its experimental Alzheimer's drug, simufilam, has garnered significant attention within the medical and research communities, as well as among regulatory bodies and patient advocacy groups. Allegations of data manipulation and scientific

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later